SK51112005A3 - Tablety deramciklan-fumarátu - Google Patents

Tablety deramciklan-fumarátu Download PDF

Info

Publication number: SK51112005A3
Authority: SK; Slovakia
Prior art keywords: tablets; weight; tablets according; microcrystalline cellulose; particle size
Prior art date: 2003-06-03

Application number

SK5111-2005A

Other languages

English (en)

Slovak (sk)

Inventor

P�L Fekete

L�Szl�N� Maroshelyi

Zsolt Zsigmond

L�Szl�N� G�Ra

Husz�R Magdolna Leventiszn�

Istv�Nn� J�Mbor

J�Zsef Tari

Original Assignee

Egis Gy�Gyszergy�R Rt.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-03

Filing date

2004-06-03

Publication date

2006-06-01

2004-06-03 Application filed by Egis Gy�Gyszergy�R Rt. filed Critical Egis Gy�Gyszergy�R Rt.

2006-06-01 Publication of SK51112005A3 publication Critical patent/SK51112005A3/sk

Links

RFQWRWCCNQNACG-HJYQBBATSA-N (e)-but-2-enedioic acid;n,n-dimethyl-2-[[(1r,3s,4r)-4,7,7-trimethyl-3-phenyl-3-bicyclo[2.2.1]heptanyl]oxy]ethanamine Chemical compound OC(=O)\C=C\C(O)=O.C1([C@@]2([C@]3(C)CC[C@@H](C3(C)C)C2)OCCN(C)C)=CC=CC=C1 RFQWRWCCNQNACG-HJYQBBATSA-N 0.000 title claims abstract description 50
229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 50
239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 50
235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 49
239000002245 particle Substances 0.000 claims abstract description 44
239000011230 binding agent Substances 0.000 claims abstract description 25
239000000314 lubricant Substances 0.000 claims abstract description 16
239000007884 disintegrant Substances 0.000 claims abstract description 13
239000000945 filler Substances 0.000 claims abstract description 10
229920000168 Microcrystalline cellulose Polymers 0.000 claims description 49
239000008187 granular material Substances 0.000 claims description 34
239000000203 mixture Substances 0.000 claims description 32
238000005469 granulation Methods 0.000 claims description 30
230000003179 granulation Effects 0.000 claims description 30
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 24
235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 23
229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 20
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 18
238000000034 method Methods 0.000 claims description 17
239000007788 liquid Substances 0.000 claims description 16
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 13
239000001267 polyvinylpyrrolidone Substances 0.000 claims description 13
239000000243 solution Substances 0.000 claims description 13
235000019359 magnesium stearate Nutrition 0.000 claims description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
239000008119 colloidal silica Substances 0.000 claims description 11
239000001768 carboxy methyl cellulose Substances 0.000 claims description 10
239000003795 chemical substances by application Substances 0.000 claims description 9
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 9
229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 9
229920002472 Starch Polymers 0.000 claims description 8
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 7
229940069328 povidone Drugs 0.000 claims description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
238000002360 preparation method Methods 0.000 claims description 6
239000008107 starch Substances 0.000 claims description 6
235000019698 starch Nutrition 0.000 claims description 6
229920000609 methyl cellulose Polymers 0.000 claims description 4
239000001923 methylcellulose Substances 0.000 claims description 4
235000010981 methylcellulose Nutrition 0.000 claims description 4
235000000346 sugar Nutrition 0.000 claims description 4
108010010803 Gelatin Proteins 0.000 claims description 3
239000007864 aqueous solution Substances 0.000 claims description 3
229940075614 colloidal silicon dioxide Drugs 0.000 claims description 3
229920000159 gelatin Polymers 0.000 claims description 3
239000008273 gelatin Substances 0.000 claims description 3
235000019322 gelatine Nutrition 0.000 claims description 3
235000011852 gelatine desserts Nutrition 0.000 claims description 3
239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 3
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
239000011734 sodium Substances 0.000 claims description 3
229920002261 Corn starch Polymers 0.000 claims description 2
229920001353 Dextrin Polymers 0.000 claims description 2
239000004375 Dextrin Substances 0.000 claims description 2
239000001856 Ethyl cellulose Substances 0.000 claims description 2
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
229920002907 Guar gum Polymers 0.000 claims description 2
229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
244000061456 Solanum tuberosum Species 0.000 claims description 2
235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
235000021355 Stearic acid Nutrition 0.000 claims description 2
229920000615 alginic acid Polymers 0.000 claims description 2
235000010443 alginic acid Nutrition 0.000 claims description 2
239000000783 alginic acid Substances 0.000 claims description 2
229960001126 alginic acid Drugs 0.000 claims description 2
150000004781 alginic acids Chemical class 0.000 claims description 2
CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 2
239000008116 calcium stearate Substances 0.000 claims description 2
235000013539 calcium stearate Nutrition 0.000 claims description 2
235000019425 dextrin Nutrition 0.000 claims description 2
150000002148 esters Chemical class 0.000 claims description 2
235000019325 ethyl cellulose Nutrition 0.000 claims description 2
229920001249 ethyl cellulose Polymers 0.000 claims description 2
239000000665 guar gum Substances 0.000 claims description 2
235000010417 guar gum Nutrition 0.000 claims description 2
229960002154 guar gum Drugs 0.000 claims description 2
239000008172 hydrogenated vegetable oil Substances 0.000 claims description 2
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
229920001592 potato starch Polymers 0.000 claims description 2
235000015424 sodium Nutrition 0.000 claims description 2
229910052708 sodium Inorganic materials 0.000 claims description 2
239000008117 stearic acid Substances 0.000 claims description 2
229940100445 wheat starch Drugs 0.000 claims description 2
MGUOYHYADSTQRB-WLHGVMLRSA-N (e)-but-2-enedioic acid;heptan-2-one Chemical compound CCCCCC(C)=O.OC(=O)\C=C\C(O)=O MGUOYHYADSTQRB-WLHGVMLRSA-N 0.000 claims 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
240000007472 Leucaena leucocephala Species 0.000 claims 1
235000010643 Leucaena leucocephala Nutrition 0.000 claims 1
240000008042 Zea mays Species 0.000 claims 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 1
235000002017 Zea mays subsp mays Nutrition 0.000 claims 1
235000005822 corn Nutrition 0.000 claims 1
MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 claims 1
239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
229940045902 sodium stearyl fumarate Drugs 0.000 claims 1
238000006467 substitution reaction Methods 0.000 claims 1
239000004480 active ingredient Substances 0.000 abstract description 31
239000002249 anxiolytic agent Substances 0.000 abstract description 2
230000000949 anxiolytic effect Effects 0.000 abstract description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
239000000853 adhesive Substances 0.000 abstract 1
230000000181 anti-adherent effect Effects 0.000 abstract 1
239000000843 powder Substances 0.000 description 17
229950011405 deramciclane Drugs 0.000 description 13
QOBGWWQAMAPULA-RLLQIKCJSA-N n,n-dimethyl-2-[[(1r,3s,4r)-4,7,7-trimethyl-3-phenyl-3-bicyclo[2.2.1]heptanyl]oxy]ethanamine Chemical compound C1([C@@]2([C@]3(C)CC[C@@H](C3(C)C)C2)OCCN(C)C)=CC=CC=C1 QOBGWWQAMAPULA-RLLQIKCJSA-N 0.000 description 13
238000007906 compression Methods 0.000 description 12
230000006835 compression Effects 0.000 description 12
238000002474 experimental method Methods 0.000 description 9
238000003475 lamination Methods 0.000 description 9
238000004519 manufacturing process Methods 0.000 description 8
238000004090 dissolution Methods 0.000 description 7
238000005243 fluidization Methods 0.000 description 7
238000003825 pressing Methods 0.000 description 7
239000000725 suspension Substances 0.000 description 7
230000002349 favourable effect Effects 0.000 description 5
229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 4
229940063834 carboxymethylcellulose sodium Drugs 0.000 description 4
239000007888 film coating Substances 0.000 description 4
238000009501 film coating Methods 0.000 description 4
239000008194 pharmaceutical composition Substances 0.000 description 4
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
229920001531 copovidone Polymers 0.000 description 3
239000000546 pharmaceutical excipient Substances 0.000 description 3
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
238000005550 wet granulation Methods 0.000 description 3
230000000052 comparative effect Effects 0.000 description 2
239000011777 magnesium Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
239000000377 silicon dioxide Substances 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000005507 spraying Methods 0.000 description 2
239000007916 tablet composition Substances 0.000 description 2
244000215068 Acacia senegal Species 0.000 description 1
FTVDEOQVVMBHLY-UHFFFAOYSA-L C(CCCCCCCCCCCCCCCCC)(=O)[O-].C(CCCCCCCCCCCCCCCCC)[Mg+].[Na+].C(CCCCCCCCCCCCCCCCC)(=O)[O-] Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)[O-].C(CCCCCCCCCCCCCCCCC)[Mg+].[Na+].C(CCCCCCCCCCCCCCCCC)(=O)[O-] FTVDEOQVVMBHLY-UHFFFAOYSA-L 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
101000607872 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 21 Proteins 0.000 description 1
208000022120 Jeavons syndrome Diseases 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
229920000881 Modified starch Polymers 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
229920003081 Povidone K 30 Polymers 0.000 description 1
102100039918 Ubiquitin carboxyl-terminal hydrolase 21 Human genes 0.000 description 1
XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
235000019888 Vivapur Nutrition 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000012752 auxiliary agent Substances 0.000 description 1
239000002775 capsule Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
229940105329 carboxymethylcellulose Drugs 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000007907 direct compression Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
-1 however Polymers 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
229940127554 medical product Drugs 0.000 description 1
229910002055 micronized silica Inorganic materials 0.000 description 1
238000002156 mixing Methods 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
239000008213 purified water Substances 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
239000007909 solid dosage form Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
238000010998 test method Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
238000011285 therapeutic regimen Methods 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Adhesives Or Adhesive Processes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Compositions Of Macromolecular Compounds (AREA)
Materials For Medical Uses (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SK5111-2005A 2003-06-03 2004-06-03 Tablety deramciklan-fumarátu SK51112005A3 (sk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0301537A HUP0301537A3 (en)	2003-06-03	2003-06-03	Deramcyclane fumarate tablets and process for producing them
PCT/HU2004/000058 WO2004105743A1 (en)	2003-06-03	2004-06-03	Deramciclane-fumarate tablets

Publications (1)

Publication Number	Publication Date
SK51112005A3 true SK51112005A3 (sk)	2006-06-01

Family

ID=90001686

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK5111-2005A SK51112005A3 (sk)	2003-06-03	2004-06-03	Tablety deramciklan-fumarátu

Country Status (25)

Country	Link
US (1)	US20060258745A1 (is)
EP (1)	EP1628648B1 (is)
JP (1)	JP2006526603A (is)
KR (1)	KR20060015746A (is)
CN (1)	CN1832733A (is)
AT (1)	ATE381325T1 (is)
AU (1)	AU2004243240A1 (is)
BG (1)	BG109404A (is)
BR (1)	BRPI0410909A (is)
CA (1)	CA2527431A1 (is)
CZ (1)	CZ2005817A3 (is)
DE (1)	DE602004010803D1 (is)
EA (1)	EA009681B1 (is)
HR (1)	HRP20050979A2 (is)
HU (1)	HUP0301537A3 (is)
IL (1)	IL172133A0 (is)
IS (1)	IS8202A (is)
MX (1)	MXPA05013020A (is)
NO (1)	NO20056220L (is)
PL (1)	PL378540A1 (is)
RS (1)	RS20050898A (is)
SK (1)	SK51112005A3 (is)
UA (1)	UA80209C2 (is)
WO (1)	WO2004105743A1 (is)
ZA (1)	ZA200510139B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI399223B (zh) *	2006-09-15	2013-06-21	Daiichi Sankyo Co Ltd	奧美沙坦酯及氨氯地平之固體劑型
CA2937365C (en)	2016-03-29	2018-09-18	F. Hoffmann-La Roche Ag	Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
US11478467B2 (en)	2017-05-04	2022-10-25	Sreenivasarao Vepachedu	Targeted drug rescue with novel compositions, combinations, and methods thereof
CN110973635B (zh) *	2019-12-26	2022-07-29	汤臣倍健股份有限公司	一种辅料组合物及益生菌片剂
CN114643014B (zh) *	2022-05-07	2024-02-13	佛山市锦厨食品科技有限公司	一种可提高颗粒状鸡精的成型速度的食品用造粒机

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU179164B (en) *	1979-12-14	1982-08-28	Egyt Gyogyszervegyeszeti Gyar	Process for producing cycloalkyl-ethers of alkanolamines
HU214588B (hu) *	1994-07-01	1998-04-28	EGIS Gyógyszergyár Rt.	Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
AU2478900A (en) *	1998-12-18	2000-07-12	Abbott Laboratories	Controlled release formulation of divalproex sodium
HUP0103017A3 (en) *	2001-07-18	2004-05-28	Egis Gyogyszergyar Nyilvanosan	Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
PT1501484E (pt) *	2002-04-29	2006-10-31	Egyt Gyogyszervegyeszeti Gyar	Processo para a preparacao de comprimidos de substancias farmaceuticamente activas possuindo propriedades de compressao desfavoraveis com um liquido de granulacao compreendendo celulose microcristalina.

2003
- 2003-06-03 HU HU0301537A patent/HUP0301537A3/hu unknown
2004
- 2004-03-06 UA UAA200512806A patent/UA80209C2/uk unknown
- 2004-06-03 PL PL378540A patent/PL378540A1/pl not_active Application Discontinuation
- 2004-06-03 WO PCT/HU2004/000058 patent/WO2004105743A1/en not_active Ceased
- 2004-06-03 CZ CZ20050817A patent/CZ2005817A3/cs unknown
- 2004-06-03 AU AU2004243240A patent/AU2004243240A1/en not_active Abandoned
- 2004-06-03 ZA ZA200510139A patent/ZA200510139B/xx unknown
- 2004-06-03 KR KR1020057023143A patent/KR20060015746A/ko not_active Withdrawn
- 2004-06-03 CN CNA2004800170948A patent/CN1832733A/zh active Pending
- 2004-06-03 MX MXPA05013020A patent/MXPA05013020A/es not_active Application Discontinuation
- 2004-06-03 CA CA002527431A patent/CA2527431A1/en not_active Abandoned
- 2004-06-03 EA EA200501883A patent/EA009681B1/ru not_active IP Right Cessation
- 2004-06-03 BR BRPI0410909-0A patent/BRPI0410909A/pt not_active IP Right Cessation
- 2004-06-03 RS YUP-2005/0898A patent/RS20050898A/sr unknown
- 2004-06-03 US US10/559,286 patent/US20060258745A1/en not_active Abandoned
- 2004-06-03 SK SK5111-2005A patent/SK51112005A3/sk unknown
- 2004-06-03 EP EP04735926A patent/EP1628648B1/en not_active Expired - Lifetime
- 2004-06-03 AT AT04735926T patent/ATE381325T1/de not_active IP Right Cessation
- 2004-06-03 DE DE602004010803T patent/DE602004010803D1/de not_active Expired - Lifetime
- 2004-06-03 JP JP2006508403A patent/JP2006526603A/ja active Pending
- 2004-06-03 HR HR20050979A patent/HRP20050979A2/xx not_active Application Discontinuation
2005
- 2005-11-23 IL IL172133A patent/IL172133A0/en unknown
- 2005-12-28 NO NO20056220A patent/NO20056220L/no not_active Application Discontinuation
- 2005-12-28 IS IS8202A patent/IS8202A/is unknown
2006
- 2006-01-03 BG BG109404A patent/BG109404A/en unknown

Also Published As

Publication number	Publication date
CA2527431A1 (en)	2004-12-09
EP1628648A1 (en)	2006-03-01
UA80209C2 (en)	2007-08-27
EP1628648B1 (en)	2007-12-19
AU2004243240A1 (en)	2004-12-09
RS20050898A (sr)	2008-04-04
CN1832733A (zh)	2006-09-13
HUP0301537A2 (hu)	2005-03-29
PL378540A1 (pl)	2006-05-02
EA200501883A1 (ru)	2006-06-30
JP2006526603A (ja)	2006-11-24
EA009681B1 (ru)	2008-02-28
US20060258745A1 (en)	2006-11-16
NO20056220L (no)	2006-03-02
HUP0301537D0 (en)	2003-08-28
IL172133A0 (en)	2006-04-10
BRPI0410909A (pt)	2006-06-27
BG109404A (en)	2006-11-30
ZA200510139B (en)	2007-03-28
WO2004105743A1 (en)	2004-12-09
ATE381325T1 (de)	2008-01-15
IS8202A (is)	2005-12-28
MXPA05013020A (es)	2006-03-17
KR20060015746A (ko)	2006-02-20
DE602004010803D1 (de)	2008-01-31
CZ2005817A3 (cs)	2006-04-12
HRP20050979A2 (en)	2006-03-31
HUP0301537A3 (en)	2005-07-28

Publication	Publication Date	Title
KR101380088B1 (ko)	2014-04-10	약학 조성물
US20110300214A1 (en)	2011-12-08	Pharmaceutical compositions comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid
US20130122088A1 (en)	2013-05-16	Tablet formulations containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom
SK155595A3 (en)	1997-02-05	Tablet and manufacturing process thereof
EP2106789A1 (en)	2009-10-07	Pharmaceutical composition comprising candesartan
US20100143460A1 (en)	2010-06-10	Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
CN101087589B (zh)	2013-01-30	含有缬沙坦的固体药物组合物
JP2017122056A (ja)	2017-07-13	医薬含有造粒物の製造方法
HK1205683A1 (en)	2015-12-24	Pharmaceutical formulation having improved stability
SK51112005A3 (sk)	2006-06-01	Tablety deramciklan-fumarátu
EP3184103A1 (en)	2017-06-28	Pharmaceutical composition comprising atorvastatin or a salt thereof
CA2767560A1 (en)	2010-01-28	Atovaquone with a particle size diameter range (d90) of greater than 3um to about 10um
US11260055B2 (en)	2022-03-01	Oral pharmaceutical composition of lurasidone and preparation thereof
HU227317B1 (en)	2011-03-28	Enteric coated tablet containing pantoprazole
WO2014096983A1 (en)	2014-06-26	Stable pharmaceutical compositions of saxagliptin or salts thereof
WO2023036980A1 (en)	2023-03-16	Pharmaceutical composition of bempedoic acid
WO2014118721A1 (en)	2014-08-07	Pharmaceutical oral solid dosage forms comprising valsartan and nebivolol
WO2014191443A1 (en)	2014-12-04	Method for producing dosage form comprising odanacatib

Legal Events

Date	Code	Title	Description
2010-10-07	FB9A	Suspension of patent application procedure